Indication

Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7

1 clinical trial

1 product

1 drug

Clinical trial

A Phase II Trial of MK-3475 (Pembrolizumab) and Interferon Gamma 1-b Combination Immunotherapy in Patients With Previously Treated Mycosis Fungoides and Sezary Syndrome (Treatment Group 1) and in Patients With Advanced Synovial Sarcoma (Treatment Group 2)

Status: Completed, Estimated PCD: 2021-04-08

Drug

Product

Interferon Gamma-1b